ALHC
NasdaqGSAlignment Healthcare, Inc.
Price
Key statistics
Insider activity
SEC EDGAR ↗Showing 14 recent filings. 3 other (grants, option exercises, gifts, tax withholding) are listed below but excluded from buy/sell flow.
| Insider | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|
Maroney Dawn Christine President | Option exercise | 152.07K | $9.06 | $1,377,736.08 | 2026-07-15 |
Maroney Dawn Christine President | Sell (open market) | 177.07K | $20.83 | $3,687,990.01 | 2026-07-15 |
Maroney Dawn Christine President | Option exercise | 152.07K | $9.06 | $1,377,736.08 | 2026-07-15 |
KAO JOHN E Director, Chief Executive Officer | Sell (open market) | 279.64K | $19.81 | $5,540,362.86 | 2026-07-10 |
KAO JOHN E Director, Chief Executive Officer | Sell (open market) | 18.36K | $20.65 | $378,998.17 | 2026-07-10 |
Hochradel Shane J. Chief Operations Officer | Grant / award | 87.72K | $0.00 | — | 2026-07-01 |
KONOWIECKI JOSEPH S Director, EVP, Corporate Affairs | Sell (open market) | 25K | $24.00 | $600,000.00 | 2026-07-01 |
KONOWIECKI JOSEPH S Director, EVP, Corporate Affairs | Sell (open market) | 25K | $23.00 | $575,000.00 | 2026-06-26 |
KONOWIECKI JOSEPH S Director, EVP, Corporate Affairs | Sell (open market) | 25K | $22.00 | $550,000.00 | 2026-06-18 |
Maroney Dawn Christine President | Sell (open market) | 30K | $19.55 | $586,425.00 | 2026-06-15 |
Kim Hyong Chief Medical Officer | Sell (open market) | 35.95K | $19.86 | $713,947.31 | 2026-06-12 |
KONOWIECKI JOSEPH S Director, EVP, Corporate Affairs | Sell (open market) | 25K | $21.00 | $525,000.00 | 2026-06-11 |
KAO JOHN E Director, Chief Executive Officer | Sell (open market) | 74.94K | $19.65 | $1,472,350.02 | 2026-06-10 |
KAO JOHN E Director, Chief Executive Officer | Sell (open market) | 223.06K | $20.60 | $4,594,270.76 | 2026-06-10 |
Source: SEC EDGAR Forms 4/4A (CIK 1832466). Click an insider to open the original filing.
Social sentiment
Volume-weighted across live social sources
$CLOV member growth is going to be massive next year. Who thinks it’s priced in? A year or 2 behind $ALHC Only thing to analyze before Counterpart takes the drivers seat
$ALHC certainly like this stock. I think i need to discuss what would happen when government programs change policy to determine the potential structural/existential risks. Othereise interesting entry.
$CLOV is down with this $ALHC garbage stock again
Vector Intelligence (VI) is an algorithm designed to predict potential outsized intraday moves. VI will select up to 4 stocks per day. Today's VI stocks: $ALHC, $AXTI, $RBLX, $RDDT.
$ALHC (-15.6% pre) Alignment Healthcare LLC earnings beat by $0.04, revenue fell short of estimates https://ooc.bz/l/109459
$CLOV - $ALHC 👨🏽🍳 📕 and the stock still 📈 🚀
$ALHC sold all my alhc and bought $CLOV
$CLOV $ALHC FCF flipped negative. That’s why stock is taking a shit
$CLOV $ALHC My interpretation The quarter itself appears strong: very high membership growth; solid MBR; substantial adjusted EBITDA growth; continued GAAP profitability; guidance floors raised. But the report may be disappointing relative to expectations because: Revenue was close to consensus, rather than a large beat. The EBITDA guidance ceiling remained at $163M. Only $3.5M was added to the FY EBITDA midpoint despite a roughly $13M Q2 beat versus prior midpoint guidance. The implied H2 EBITDA outlook fell by approximately $9.6M. Management is apparently preserving substantial room for H2 medical-cost seasonality and investment spending. The stock’s valuation required a cleaner beat-and-raise result. So the correct characterization is not “bad earnings.” It is closer to: Excellent backward-looking Q2 results, but a surprisingly cautious forward profitability outlook. That forward-guidance disconnect is exactly the kind of issue generic AI earnings summaries frequently fail to identify.
$ALHC
$CLOV - $ALHC didn't get a trophy from cms this week
$CLOV what on earth is going on with AH reaction to $ALHC earnings? Look good to me...
Latest news
Alignment Healthcare (ALHC) Stock Trades Down, Here Is Why
ALHC Q2 Deep Dive: Investments in Clinical Innovation and Member Growth Drive Mixed Market Response
Alignment Healthcare Inc (ALHC) (Q2 2026) Earnings Call Highlights: Record Membership Growth ...
Alignment Healthcare (ALHC) Q2 2026 Earnings Call Transcript
Compared to Estimates, Alignment Healthcare (ALHC) Q2 Earnings: A Look at Key Metrics
Alignment Healthcare Q2 Earnings Call Highlights
Alignment Healthcare (ALHC) Beats Q2 Earnings and Revenue Estimates
Alignment Healthcare Q2 Earnings, Revenue Rise; Issues Q3, Full-Year Revenue Guidance
Alignment Healthcare: Q2 Earnings Snapshot
Alignment Healthcare (NASDAQ:ALHC) Beats Q2 CY2026 Sales Expectations But Stock Drops
Get insider-buy alerts
Free weekly digest of the most notable SEC insider purchases — plus early access to real-time alerts on your watchlist.